Zhe Huang

Central South University - Hunan Cancer Hospital

Changsha, 410013

China

SCHOLARLY PAPERS

3

DOWNLOADS

162

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Overall Survival According to Time-of-Day of Treatment Administration in 713 Patients Receiving Immunochemotherapy as First Line Treatment Protocol for Advanced Non-Small Cell Lung Cancer: A Bicentric Bicontinental Study

Number of pages: 25 Posted: 18 Oct 2024
Central South University - Hunan Cancer Hospital, University of Paris-Saclay, Central South University - Department of Medical Oncology, University of Paris-Saclay, Central South University - Hunan Cancer Hospital, University of Paris-Saclay, Central South University - Hunan Cancer Hospital, Université Paris XIII Nord - Avicenne Hospital, Central South University - Hunan Cancer Hospital, Université Paris XIII Nord - Avicenne Hospital, Central South University - Hunan Cancer Hospital, Université Paris XIII Nord - Avicenne Hospital, Central South University - Department of Dermatology, Central South University - Department of Dermatology, Qinghai Provincial People's Hospital - Department of Medical Oncology, University of Versailles - Clinical Research Unit, Northeastern Great Paris Hospital Group, Central South University - Hunan Cancer Hospital, University of Paris-Saclay, Central South University - Department of Medical Oncology, Hôpital Avicenne (APHP), Central South University - Department of Medical Oncology and University of Paris-Saclay - UPR “Chronothérapie, Cancers, et Transplantation”
Downloads 87 (639,457)

Abstract:

Loading...

Circadian rhythms, Chronotherapy, Immune checkpoint inhibitors, Time of day of administration, Lung cancer, Immuno-chemotherapy, Chronopharmacology, Circadian medicine

2.

Potential Utility of Albumin-Bilirubin (ALBI) and Body Mass Index (BMI)-Based Logistic Model to Predict Survival Outcome in Non-Small Cell Lung Cancer with Liver Metastasis Treated with PD-1 Inhibitor

Number of pages: 52 Posted: 21 Aug 2023
Central South University - Department of Medical Oncology, Qinghai Provincial People's Hospital - Department of Medical Oncology, Central South University - Hunan Cancer Hospital, Shanghai Jiao Tong University (SJTU), Hunan University of Medicine - Department of Medical Oncology, Central South University - Hunan Cancer Hospital, Central South University - Hunan Cancer Hospital, Central South University - Hunan Cancer Hospital, Central South University - Hunan Cancer Hospital, Central South University - Hunan Cancer Hospital, Central South University - Hunan Cancer Hospital, Central South University - Hunan Cancer Hospital, Huazhong University of Science and Technology - Cancer Center, Huazhong University of Science and Technology - Cancer Centre, Central South University - Hunan Cancer Hospital, Central South University - Hunan Cancer Hospital, Huazhong University of Science and Technology - Cancer Centre, Central South University - Hunan Cancer Hospital, Central South University - Hunan Cancer Hospital, Central South University - Hunan Cancer Hospital, Central South University - Hunan Cancer Hospital, Central South University - Hunan Cancer Hospital, Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology and Central South University - Department of Medical Oncology
Downloads 39 (960,288)

Abstract:

Loading...

albumin-bilirubin grading system, immune checkpoint inhibitor, liver metastasis non-small cell lung cancer, prognostic markers

3.

PD-1 Blockade Plus Chemotherapy for EGFR-Mutant, EGFR Tyrosine Kinase Inhibitor-Pretreated Non-Small Cell Lung Cancer: A Multicenter Retrospective Study on Efficacy and Biomarker Exploration

Number of pages: 66 Posted: 31 May 2022
Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Qinghai Provincial People's Hospital - Department of Medical Oncology, Shanghai Jiao Tong University (SJTU) - Department of Pathology, Hunan University of Medicine - Department of Medical Oncology, Central South University - Hunan Cancer Hospital, Central South University - Hunan Cancer Hospital, Central South University - Hunan Cancer Hospital, Central South University - Hunan Cancer Hospital, Central South University - Hunan Cancer Hospital, Central South University - Hunan Cancer Hospital, Central South University - Hunan Cancer Hospital, Huazhong University of Science and Technology - Cancer Center, Huazhong University of Science and Technology - Cancer Centre, Central South University - Hunan Cancer Hospital, Central South University - Hunan Cancer Hospital, Huazhong University of Science and Technology - Cancer Centre, Central South University - Department of Medical Oncology and Central South University - Department of Medical Oncology
Downloads 36 (990,534)

Abstract:

Loading...

Non-small cell lung cancer, immune checkpoint inhibitor, EGFR, tyrosine kinase inhibitors, lymphocyte subsets model